Surgery, Gastroenterology and Oncology
Official journal of the International Association of Surgeons, Gastroenterologists and Oncologists
Honorary Editor-in-Chief
Masatoshi MAKUUCHI, M.D., Ph.D., FACS
Tokyo, Japan
Honorary Editor-in-Chief
Professor Masatoshi MAKUUCHI is the President of the Towa Hospital, an Emeritus President of the Japanese Red Cross Medical Center (Tokyo, Japan), and an Emeritus Professor of the University of Tokyo.
Ongraduating from the University of Tokyo, School of Medicine in 1973, hewent on to be trained as a surgeon at the 2nd Department of Surgery, University of Tokyo. After servingat regional hospitalsfrom the period of 1973 to 79, he went on to workat the National Cancer Center Japan, Department of Surgery, specializing in HBP surgery. At the Cancer Center, he was appointed as Head surgeon of the Hepatobiliary Division in 1988, and then as Chief Surgeon of the Operation Department in 1989. In October1989, he became Professor and Chairmanofthe 1stDepartment of Surgery, Shinshu University, School of Medicine (Nagano, Japan).
He moved back from Shinshu to Tokyo in 1994 to be appointed as Professor and Chairman for the 2ndDepartment of Surgery, University of Tokyo, Faculty of Medicine. He then went on to serve as Professor and Chairman for Hepatobiliary Pancreatic Surgery Division, and Artificial Organ and Transplantation Surgery Division of Department of Surgery, University of Tokyo,Graduate School of Medicine.
From 2007 to 2017, he served as President of the Japanese Red Cross Medical Center until he moved to the current positionat TOWA Hospital in April 2017.
Curriculum Vitae
Editor in Chief
Dr. Nuh Rahbari, MD
Ulm, Germany
Editor-in-Chief
Dr. Nuh Rahbari received his medical degree from the Technical University of Munich, Germany in 2006. He commenced his surgical residency at the Universityhospital Heidelberg, Germany and joined the Edwin L. Steele Laboratories for Tumor Biology, Harvard Medical School and Massachusetts General Hospital, Boston, USA for a postdoctoral research fellowship from 2011-2013.
After completion of his surgical training, he was appointed faculty and director of the Clinical Trial Unit at the Department of Surgery, University Hospital Dresden in 2015. From 2016-2017, he did a fellowship in Surgical Oncology at Memorial Sloan-Kettering Cancer Center, New York, USA. In 2018, Dr. Rahbari joined the Department of Surgery, University of Medicine Mannheim, University of Heidelberg, Germany, where he served as the Vice Chairman and Chief of the hepatobiliary and pancreatic (HPB) surgery service until 2023. He is currently a Professor and Chief of Surgery at Ulm University, Germany.
Dr. Rahbari’s has published extensively in the field of surgical oncology. His research focusses on the mechanisms of disease progression and the multi-disciplinary treatment of primary and secondary hepatic malignancies. He serves as a reviewer for several federal funding agencies as well as scientific journals and has initiated multiple clinical trials in the field of metastatic colorectal cancer, hepatic and pancreatic surgery.
Vice Editor in Chief
Irinel Popescu, MD, Ph.D.
Bucharest, Romania
Vice Editor-in-Chief
Irinel Popescu, MD, FACS, FEBS, Professor of Surgery, Head of the "Dan Setlacec" Center of General Surgery and Liver Transplantation, Fundeni Clinical Institute, Bucharest, Romania, President of the Romanian Association of Hepato-Bilio-Pancreatic Surgery and Liver Transplant.
Curriculum Vitae
Founding Editors
Dan G. Duda, DMD, Ph.D., AIMBE Fellow
Boston, USA
Founding Editor
Dan G. Duda, DMD, PhD, Director of Translational Research in GI Radiation Oncology, Investigator, Edwin L. Steele Laboratories for Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital, Associate Professor of Tumor Biology, Harvard Medical School, Charlestown, MA, USA.
Dr. Duda’s area of research is tumor interaction with its microenvironment and its impact on resistance to immunotherapy, antiangiogenesis and cytotoxic therapies. Over the last decade and a half, he built an independent and strong Liver Cancer Research Program. The translational goal of this program increasing the durability of response to available therapies. The basic research goal is to identifying new cellular and molecular mechanisms of local and metastatic tumor progression and treatment resistance and validate them as new targets for cancer treatment.To this end, his group studying the activity in this combinatorial setting of antiangiogenic drugs, antifibrotic drugs or radiotherapy approaches using preclinical studies that reproduce the hallmarks of human cancers. In parallel, they are conducting studies of biomarkers of response in correlative clinical studies in cancer patients He has authored over 225 publications so far, of which 140+ are original reports, including in basic research journals such as Nature, Nature Medicine, Nature Biotechnology, Nature Genetics, Cell, Cancer Cell, and Science Translational Medicine, and in clinical journals such as Journal of Clinical Oncology and JAMA Oncology.
He is a Founding Editor of the Surgery, Gastroenetrology and Oncology, a Senior Associate Editor of the International Journal of Radiation Oncology*Biology*Physics, and an Editorial Board member for several other journals, including Clinical & Translational Radiation Oncology, Journal of Hepatocellular Carcinoma and Cancers. Heis currently serving as the Secretary General of the IASGO.Dr. Duda was elected as an Honorary Member of the Academy of Medical Sciences of Romania in 2012, and in the College of Fellows of the American Institute for Medical and Biomedical Engineering in 2020.
Curriculum Vitae
Kyoichi Takaori, MD, Ph.D., FACS, FMAS(hon.), AGAF
Kyoto, Japan
Founding Editor
Director, Pancreatic Cancer Unit, Kyoto University Hospital Cancer Center, Kyoto, Japan
Dr. Kyoichi Takaori is a pancreatic surgeon who has extensive experiences of open, laparoscopic, and robotic surgery. His academic career includes Professor of Surgery at Asahi University and Assistant Professor of Physiology and Biophysics at University of Arkansas for Medical Sciences.
Thorough his career as a surgeon, he has struggled to improve the prognosis of pancreatic cancer, which is known as the worst malignancy. First, he has focused on early detection of pancreatic cancer so that surgeons can offer truly curative operations to the patients. In 2003, with Dr. Ralph Hruban, Dr. Takaori organized International Expert Meeting on Precursor Lesions of Pancreatic Cancer and created international consensus on the classification of pancreatic intraepithelial neoplasia (PanIN) and intraductal papillary mucinous neoplasm (IPMN).
World Health Organization has adopted this classification system, which helps investigators better understand the precursor lesions. Furthermore, in pursuit of early diagnosis and treatment of pancreatic cancer in high-risk individuals, he has founded a Japanese Familial Pancreatic Cancer Registry and is promoting collateral studies as the chairman of the registry committee of Japan Pancreas Society. Second, he has endeavored to improve the surgical techniques for pancreatic malignancies. In order to improve local control and to perform more oncologic resections, he has refined artery-first pancreatoduodenectomy and developed new techniques of artery-first distal pancreatectomy, and artery-first DP-CAR by utilizing the “Tiger’s Den” approach in all open, laparoscopic and robotic surgery. Third, he is a great believer of multi-disciplinary approach and presently directing the multi-disciplinary team as the Head of Pancreatic Cancer Unit at Kyoto University Hospital.
Recently, he has conducted international collaborative study on the clinical managements of pancreatic cancer. Last but not least, Dr. Takaori has served patient’s activities on the Medical Advisory Board for PanCAN Japan and the Scientific Advisory Board for Pancreatic Cancer UK. He is Founding Editor of Surgery, Gastroenterology and Oncology, the official journal of the International Association of Surgeons, Gastroenterologists and Oncologists (IASGO), and has served Pancreatology also as the Vice Editor-in-Chief of Pancreatology for over eight years. Along with Prof. Dan Duda, Prof. Takaori is organizing IASGO World Congresses as well as many Postgraduate Courses for the purpose of “Globalization of Medical Knowledge” all over the world.
Curriculum Vitae
Consultant Editor
Guido Torzilli, MD, Ph.D., FACS
Milan, Italy
Consultant Editor
Professor and Chairman, Department of General Surgery – Director
Division of Hepatobiliary and General Surgery – Humanitas University - Humanitas Research Hospital - Rozzano - Milano, Italy
Dr. Torzilli is a prominent European liver surgeon, known for his surgical and scientific activities in the field of precision surgery for malignant liver tumors. His interest in intraoperative ultrasound examination of the liver and its vascular structures led to the development of several novel techniques, such as liver tunneling, minimesohepatectomy and the upper transverse liver resection. He has been driven be the conviction, that a tailored liver surgery for malignant tumors should have the secondary goal of sparing parenchymal volume as well as the vascular skeleton of the liver. The overall strategy he dedicated much of his research and surgical activities to, has become known as parenchymal sparing liver surgery. He served as the first Editor in Chief of SGO, and is a member of the Executive Committee of IASGO.
Managing Editor
Simona Olimpia Dima, MD, Ph.D.
Bucharest, Romania
Managing Editor
Scientific Researcher I, Fundeni Clinical Institute,
Coordinator Research and Development Center of Digestive Disease and Liver Transplantation
MD, PhD General Surgery, Fundeni Clinical Institute
President of the Scientific Council, Fundeni Clinical Institute (since 2017)
Scientific Coordinator of the project: POS CCE Priority Axis 2: Competitiveness through Research, Technological Development and Innovation, Operation: 2.2.1. Development of the existing C-D infrastructure and creation of new C-D infrastructures (laboratories, research centres) - 951 / code SMIS-CSNR 14056, financing contract no. 434 / 21.12.2012 - Centre of Excellence in Translational Medicine (CEMT).
Curriculum Vitae
Executive Editor
Florin Botea, MD, Ph.D.
Bucharest, Romania
Executive Editor
Florin Botea is a Lecturer of General Surgery at Faculty of Medicine - Titu Maiorescu University and Senior Surgeon in General Surgery, Specialized in HBP Surgery, Ultrasound-Guided Resections in Department of General Surgery, Center of General Surgery and Liver Transplantation, Bucharest, Romania
Curriculum Vitae
Associate Editors
Calogero Iacono, MD
Verona, Italy
Associate Editor
Department of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona Medical School Verona, Italy
Prof. Calogero Iacono is Associate Professor of Surgery at the Department of Surgery of the University of Verona Medical School, in the 2013 he has obtained the Italian Board of Professor of Surgery.
Prof. Iacono is Chief of the Unit of Hepato-Biliary-Pancreatic Surgery and Director of The Verona Multidisciplinary Hepato-Biliary Oncological Group.
Curriculum Vitae
Marco Del Chiaro, MD, Ph.D.
Stockholm, Sweden
Associate Editor
Professor, Surgery-Surgical Oncology, University of Colorado Division Chief, Surgical Oncology, Clinical Director, Hepato-Pancreato-Biliary Program.
Marco Del Chiaro, MD, PhD, received his medical degree from Pisa University, Italy, where he also completed his residency in general and transplant surgery.
He received his PhD degree in new technologies for health from the same institution. Dr Del Chiaro is presently an associate professor of surgery in the Division of Surgery, Department of Clinical Science, Intervention, and Technology at Karolinska Institute, Stockholm, Sweden. Dr Del Chiaro is revisor of the European Pancreatic Club and the United European Gastroenterology Federation's Future Trends Committee member, and he is the founder and coordinator of the Italian Registry of Familial Pancreatic Cancer, of the Young Pancreatologist Platform in Europe and of the European Study Group on Cystic Tumors of the Pancreas.
He is a hepatobiliary surgeon specializing in pancreatic diseases, transplantation, and robotic surgery.
Masato Nagino, MD, Ph.D.
Nagoya, Japan
Associate Editor
Department of Surgery, Division of Surgical Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Prof. Masato Nagino, is chairman, division of surgical oncology, first department of surgery, Nagoya University. Approximately 100–120 liver operations were performed annually at his institution, of which close to 80 are performed to treat hilar cholangiocarcinoma, making Nagoya University the world leader in the management of this disease.
Curriculum Vitae
Ming-Tsan Lin, MD, Ph.D.
Taipei, Taiwan
Associate Editor
Lin Ming-Tsan is the professor of surgery at National Taiwan University Hospital and College. Prof. Lin, with many works to his credit, is one of the pioneer in developing minimally invasive surgery regarding gastrointestinal diseases in Asia. Being honored as the emeritus chair of the Taiwan Surgical Society of Gastroenterology, Prof. Lin also devoted in the research of the nutrition for surgical treatment and severe illness. His team has initiated and settled the total parenteral nutrition program in Taiwan, as well as consecutive publications in scientific documents.
Curriculum Vitae
Mustapha Adham, MD
Lyon, France
Associate Editor
Professor of Digestive Surgery
Department of HBP Surgery and Liver Transplantation
Edouard Herriot Hospital, Hospices Civils de Lyon, France
Professor Mustapha Adham is the President of IASGO 2017. He is also the Director of the world renowned HBPSurG, an exciting multidisciplinary annual meeting under the auspices of IASGO and other international organizations. HBPSurG gathers World-leaders in hepatobiliary & pancreatic diseases, surgery, and oncology for an outstanding interdisciplinary scientific program and to contribute to the learning of young HBP specialists and trainees.
Norihiro Kokudo, MD, PhD
Tokyo, Japan
Associate Editor
Dr. Norihiro Kokudo is the President of National Center for Global Health and Medicine in Tokyo. He earned his M.D. in 1981, and then Ph.D. in 1988 at University of Tokyo. From 1989 to 1991 he stayed at Department of Surgery, University of Michigan as a visiting research investigator. After 6 years at Cancer Institute Hospital, Tokyo, as a senior staff of GI surgery, he joined the Department of HPB Surgery in The University of Tokyo and became a professor and chairman in 2007 (until March 2017). Dr. Kokudo has been conducting a number of research projects on surgical treatment of HCC, colorectal liver metastases, and living donor liver transplantation. As the chairman of the guideline committee, he compiled 3rd and 4th version of Japanese clinical practice guidelines for HCC in 2013 and 2017. Dr. Kokudo is the past president of Japan Surgical Society and Asian-Pacific Hepato-Pancreato-Biliary Association (A-PHPBA). He is the president-elect of International Hepato-Pancreato-Biliary Association (IHPBA) and a Vice President of International Association of Surgeons, Gastroenterologists and Oncologists (IASGO). He is also a fellow of American College of Surgeons and Royal College of Surgeons of England, and a member of International Society of Surgery. He is an honorary regional editor for HPB, Co-editor-in-Chief for Global Health and Medicine, and an associate editor for Liver Cancer and Digestive Surgery. He is on the editorial board of Annals of Surgery, Surgery, Journal of American College of Surgeons, World Journal of Surgery, and Journal of HPB Science.
Curriculum Vitae
Prof. Ho-Seong Han, M.D., Ph.D
Seoul, Korea
Associate Editor
Professor of Department of Surgery, Seoul National University College of Medicine, Seoul National University Bundang Hospital(SNUBH)
Prof. Han graduated from Seoul National University College of Medicine in 1984, and finished internship and residency of department of Surgery at Seoul National University Hospital in 1988 and received his Ph.D from the same institution.
His fields of interests are hepatobiliary surgery and laparoscopic surgery.
Currently he’streasurer of IASGO, President-elect of Korean Society of HBP Surgery, President of the Korean Study Group of Laparoscopic Liver Surgery, ex-Chairman of Korean Society of Endoscopic & Laparoscopic Surgery, ex-Chairman of Korean Society of Surgical Oncology and ex-President of the Korean Society of Traumatology and president of the Parenteral & Enteral Nutrition Society of Asia (PENSA), as well as Chairman of the Korean Society of Parenteral and Enteral Nutrition (KSPEN), Vice President of IASMEN(International Association of Surgical Metabolism and Nutrition)other relevant international societies.
Prof. Han is an Editor of SGO(Surgery, Gastroenterology and Oncology), Ann Surgery, Surgery, Associate Editor of Digestive Surgery, and editor of the Journal of HBPS, World J Clin Oncology, Surgical Oncology, World J of Gastroenterology, HBSN(HepatoBiliary Surgery and Nutrition) and Scientific advisor of Ann Surgical Oncol, and Reviewer ofClinical Nutrition, JACS, British J Surgery, WJS, J SurgOncol, HPB, Pancreas, Surgical Endoscopy, J GastointestinalSurg,HepatologyInt, Hepatogastroenterology, etc.
Sergey Voskanyan, MD, Ph.D.
Moscow, Russia
Associate Editor
State Research Center Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency of Russia.
Professor Sergey Voskanyan is the President of IASGO 2018 held in Moscow, Russia. He is the Head of the Center for Surgery and Transplantology,
Vijay Khatri, MBChB, MBA, FACS
Elk Grove, USA
Associate Editor
Vijay P. Khatri, MBChB, MBA, FACS
Assistant Dean of Faculty Affairs and Development
Director, M4 Electives and Sub-internships
Professor of Surgery and Oncology
California Northstate University College of Medicine
Dr. Khatri is an experienced academic surgical oncologist and physician executive with experience in cancer surgery, organizational change management, operational optimization and team building to achieve best outcomes for patients, staff, physicians and the communities we serve. He serves as the Editor in Chief or the Surgical Oncology journal.
Yasuhiro Kodera, MD, Ph.D., FACS
Nagoya, Japan
Associate Editor
Professor, Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
Dr. Kodera is Director at Nagoya University Hospital. Alongside his continuing job as a consultant for gastric surgery and multimodality treatment, he is in charge of clinical and research works at a department where main disease of interest are cancers of the esophagus, stomach, colon/rectum, pancreas, and liver, and inflammatory bowel disease.
Editorial Board
Abdel-Hadi Al Breizat, MD, Ph.D.
Abdel-Hadi Al Breizat
Editorial Board
Dr. Abdel-Hadi Al Breizat is the President of Jordanian Surgical Society. He serves as the Chief Surgical Specialty/Ministry of Health of Jordan.
Curriculum Vitae
Ahmed Kaseb, MD
Houston, USA
Editorial Board
Dr. Ahmed Omar Kaseb is Professor and Program Director of Hepatocellular Carcinoma (HCC), at the Department of Gastrointestinal Medical Oncology at the University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
He is PI and Director of The University of Texas MD Anderson NIH SPORE grant in HCC.
Curriculum Vitae
Aleksandar Karamarkovic, MD, Ph.D., FACS
Belgrade, Serbia
Editorial Board
Aleksandar Karamarkovic, Professor of Surgery, Faculty of Medicine University of Belgrade, Director, Clinic for Surgery, University Clinical Center “Zvezdara”, Belgrade, Serbia.
Dr. Karamarkovic Professor of Surgery at Faculty of Medicine University of Belgrade. He organized “The First Regional Meeting of IASGO in Belgrade: Postgraduate Course in HBP Surgery and Research” in September 2019.
He is leading the effort to establishing stronger collaborations among the IASGO Chapters in South-Eastern European area.
Curriculum Vitae
Alvin Silva, MD
Phoenix, USA
Editorial Board
Professor of Radiology, Mayo Clinic College of Medicine.
Dr. Alvin C Silva specializes in diagnostic radiology in Scottsdale, AZ and has over 3 decades of experience in the field of medicine. He graduated from Wright State University School Of Medicine with his medical degree in 1991.
He is affiliated with numerous hospitals in Arizona and more, including Mayo Clinic Hospital.
Curriculum Vitae
Andrew X. Zhu, MD, Ph.D.
Shanghai, China
Editorial Board
Director, Jiahui International Cancer Center Director, Experimental Therapeutics and Clinical Research, Jiahui Director Emeritus, Massachusetts General Hosptial Cancer Center Professor of Medicine, Harvard Medical School
Dr. Andrew X. Zhu is a Professor of Medicine at Harvard Medical School and Director of Liver Cancer Research at Massachusetts General Hospital. His clinical practice focuses on medical and multidisciplinary management of patients with gastrointestinal cancers including liver, bile duct, colorectal, pancreatic, gastroesophageal, and neuroendocrine cancers. Dr. Zhu is an internationally recognized expert in hepatocellular carcinoma and cholangiocarcinoma. Since 2019, he also serves as the Director of Jiahui International Cancer Center.
Brian K. P. Goh, MBBS, MMED, MSC, FRCSEd
Singapore, Singapore
Editorial Board
Professor Brian K. P. Goh is presently senior consultant surgeon and adjunct professor at the Department of Hepatopancreatobiliary (HPB) and Transplant Surgery, Singapore General Hospital. He is Deputy Head at the SingHealth-Duke National University of Singapore Liver Transplant center and also serves as both the director of pancreatic surgery and director of robotic surgery in his department.
Curriculum Vitae
Camilo Correa, MD
Editorial Board
Camilo Correa, MD is a surgical oncologist with a focus on cancer of the liver, pancreas, bile ducts, and upper gastrointestinal tract (stomach and duodenum). As a general surgical oncologist he is trained in management of a wide variety of malignancies and in the multidisciplinary treatment of patients with cancer. He specializes in minimally invasive techniques, laparoscopy and robotic surgery, for both benign and malignant conditions.
Dr. Correa completed his surgical residency at Indiana University School of Medicine and completed a complex general surgical oncology fellowship at Memorial Sloan Kettering Cancer Center in New York.
Ching-Yao Yang, MD, Ph.D.
Taipei, Taiwan
Editorial Board
Ward Director of Pancreas, Endocrine, and UGI Surgery, Department of Surgery, National Taiwan University Hospital, and College of Medicine, National Taiwan University.
Curriculum Vitae
Cristina R. Ferrone, MD
Boston, USA
Editorial Board
Cristina R. Ferrone, MD, General & Gastrointestinal Surgery, Massachusetts General Hospital.
Dr. Ferrone is a Gastrointestinal Surgeon. She serves as the Director of the MGH Liver Surgery Program. She is also an associate professor of surgery at Harvard Medical School.
Dana Tomescu, MD, Ph.D.
Bucharest, Romania
Editorial Board
Professor in Anaesthesia and Critical Care, Head of Anaesthesia and Intensive Care Department III, Fundeni Clinical Institute, Medical Director of the Institute of Digestive Disease and Liver Transplantation.
Since 2000, Dr. Tomescu works in the liver transplant program. She is the main coordinator in anesthesia and intensive care of this program. She brings a substantial contribution in the training of specialists in anesthesia and intensive care of the Department of Anesthesiology and Resuscitation on the issues of anesthesiological insurance of liver transplantation and postoperative management of the transplanted patient.
Curriculum Vitae
Doris Henne-Bruns, MD, Ph.D.
Ulm, Germany
Editorial Board
Doris Henne-Bruns, Chairman, Professor of Surgery, Department of General and Visceral Surgery, University of Ulm, Germany https://www.uniklinik-ulm.de/allgemein-und-viszeralchirurgie.html
Curriculum Vitae
Elena Usova, MD, Ph.D.
Moscow, Russia
Editorial Board
Elena Usova, MD, PhD, A.V. Vishnevsky Institute of Surgery, Moscow, Russia
Curriculum Vitae
Ender Dulundu, MD, FACS
Istanbul, Turkey
Editorial Board
Ender Dulundu, MD, FACS, Professor of Surgery, HPB Surgery & Head of Liver Transplantation Unit Marmara University, School of Medicine, Istanbul, Turkey.
Giovanni Dapri, MD, Ph.D.
Brussels, Belgium
Editorial Board
Giovanni Dapri is Professor of Anatomy and Surgery in Brussels (Belgium). He is Founder and Director of the International School Reduced Scar Laparoscopy.He edited 5 books, published more than 140 scientific articles, presented more than 450 oral presentations worldwide and performed more than 100 laparoscopic procedures in front of an audience.He invented a set to operate through Single Incision Laparoscopy, and throughTransAnal Minimally Invasive Surgery.
Jan Lerut, MD, Ph.D.
Brussels, Belgium
Editorial Board
Department of Abdominal Surgery and Transplantation, Catholic University of Louvain, Belgium.
Dr. Lerut is a Professor Emeritus of Surgery, Director of the Starzl Abdominal Transplant Unit, University Hospitals Saint Luc and UCL Transplant Centre in Brussels; and Past President, European Society of Organ Transplantation and International Society of Liver Transplantation.
Jeffrey W. Clark, MD, Ph.D.
Boston, USA
Editorial Board
Jeffrey W. Clark, Associate Professor, Medicine, Harvard Medical School, Director of the Clinical Trials Core, Dana-Farber/Partners Cancer Care, Medical Director, Cancer Center Protocol Office, Massachussetts General Hospital.
The major area of his research focus is in the evaluation of new agents and approaches in phase I, pilot and early phase II trials. This includes the evaluation of pharmacokinetics and biological correlates of the activity of these agents or approaches. He is also especially interested in the development of new theraputic approaches for gastrointestestional malignancies.
Joaquim Manuel da Costa Pereira, MD, Ph.D.
Santa Maria da Feira, Portugal
Editorial Board
Joaquim Manuel da Costa Pereira, Director Surgical Service and of Colorectal Unity at Hospital de Braga, Portugal
Curriculum Vitae
John T. Mullen, MD
Boston, USA
Editorial Board
Dr. John Mullen is a surgical oncologist at the Massachusetts General Hospital (MGH) specializing in the surgical treatment of esophagogastric cancers and soft tissue sarcomas. He is the Program Director of the General Surgery Residency at MGH and is an Associate Professor of Surgery at Harvard Medical School.
Liliana G. Bordeianou, MD, MPH
Boston, USA
Editorial Board
Liliana G. Bordeianou, M.D.,M.P.H. is an as Associate Professor at Harvard Medical School and a board certified colorectal surgeon at the Massachusetts General Hospital.
Liliana Bordeianou, MD, MPH, is a board-certified colorectal surgeon and a board certified general surgeon. At the Massachusetts General Hospital, she leads as Chief of the Colorectal Surgery Program and as Director of the Pelvic Floor Disorders Center. She also serves as the Co-Chair of the Mass General Brigham Health Care Colorectal Surgery Collaborative.
Luis Ruso Martinez, MD, FACS
Editorial Board
Dr. Luis Ruso Martinez received his medical degree from the School of Medicine of the University of Republic (UdeLar) ,Montevideo, Uruguay in 1982. His doctoral thesis on Traumatic Rupture of the Thoracic Aorta was qualified as outstanding. He completed his surgical training as a resident, chief of residents and held the academic positions of Assistant and Adjoint Professor of Surgery at the Hospital de Clinicas of Montevideo and obtained the certification in surgery and in Emergentology. He completed his training abroad in University of Rennes ( France ) Hôpital de Pontchaillou con el Dr. Bernard Launois ,and begins his specialization in hepatobiliary ,pancreatic surgery (HBP) surgery when obtained the Japan Internactional Cooperation Agency ( JICA) scholarship at the National Cancer Center in Tokyo and the American College of Surgery International Scholarship with stays in Maryland Trauma Center , Pittsburg University, Mayo Clinic and University of Omaha. After completion of his surgical training, he was appointed Adjoint professor of the Surgical Basic Reserch Department of the University of Republic (UdeLar) Montevideo. In 1998 , joined the Department of Surgery, Hospital Maciel , University of Republic in Montevideo, with Dr. Raul Praderi ; where he served as Associate Professor , after Professor of Surgery and Chair of Department of Surgery ,since 2004. Dr. Ruso Martinez has published extensively in Spanish in the field of oncology and HPB surgery . His research focusses liver hydatid cyst and biliary tract specially bile duct injuries. He serves as a reviewer for several scientific journals , is fellow of many surgical societies of Latin America and is the current president of Latin American Federation of Surgery (FELAC) and Foreign Member of de AcademieNationale de Medicine (France)
Curriculum Vitae
Marco Vito Marino, MD, FEBS, FACS
Palermo, Italy
Editorial Board
Marco Vito Marino, MD FEBS(Hpb) FACS, Consultant at Emergency and General SurgeryDepartment and Supervisor of the Robotic Program at Azienda Ospedaliera, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy.
Curriculum Vitae
Masayuki Kitano, MD, Ph.D.
Wakayama, Japan
Editorial Board
Masayuki Kitano, Professor and Chairman in Second Department of Internal Medicine, Wakayama Medical University.
Curriculum Vitae
Michael Evan Lidsky, MD
Editorial Board
Dr. Lidsky completed his surgical residency at Duke University followed by subspecialty training in complex general surgical oncology and hepatopancreatobiliary surgery at Memorial Sloan Kettering Cancer Center. He returned to Duke University in 2018 as an Assistant Professor of Surgery within the Division of Surgical Oncology.
Dr. Lidsky’s clinical interests are focused on the care of patients with pre-cancerous and cancerous conditions of the liver, bile ducts, and pancreas, as well as hepatic artery infusion therapy. In addition to Dr. Lidsky’s clinical practice, his research explores functional genomic and molecular mechanisms of tumorigenesis and chemoresistance in primary liver cancer. Specifically, he uses pre-clinical models for cholangiocarcinoma to recapitulate critical events in these tumors, so as to identify mechanisms driving tumor growth, metastasis, and resistance to chemotherapy. Ultimately, this model serves as a vehicle for the discovery of new or more efficacious therapies.
Michiaki Unno, MD, Ph.D.
Sendai, Japan
Editorial Board
Department of Surgery, Tohoku University Graduate School of Medicine, Sendai, Japan
Dr. Unno is the Vice-president of Tohoku University Hospital and a Professor and Chairman of the Department of Surgery, Tohoku University Graduate School of Medicine, Japan. He has recently led a successful phase III trial of novel neoadjuvant chemotherapy in pancreatic cancer.
Curriculum Vitae
Ming Kuang, MD, Ph.D.
Editorial Board
Vice president of the First Affiliated Hospital (FAH), Sun Yat-sen University(SYSU)
Executive vice dean of Zhongshan School of Medicine, SYSU
Chief, Cancer Center, FAH-SYSU
Director, Medical Education Committee, FAH-SYSU
(Prof. Kuang is now in charge of medical education and international collaboration in both the medical school and FAH, SYSU.)
Curriculum Vitae
Mitesh J. Borad, MD
Phoenix, USA
Editorial Board
Division of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USA http://biotarget.amegroups.com/user/view/60736 https://www.mayo.edu/research/faculty/borad-mitesh-j-m-d/bio-00096700
Dr. Borad is currently an Associate Professor of Medicine at Mayo Clinic College of Medicine and Science. He also serves as the Director of the GI Cancer Cellular, Gene and Virus Therapy lab, Director of the Liver and Biliary Cancer Research Program and Deputy Director, Biomarker Discovery Program at the Center for Individualized Medicine at Mayo Clinic. Dr. Borad concurrently serves on the National Cancer Institute’s Hepatobiliary Task Force, an appointment he has held since 2011. Prior to joining Mayo Clinic, he spent three years as a Drug Development Scholar/Genomics Medicine Scholar at the Translational Genomic Research Institute, where he worked closely with world-renowned experts, including Dr. Daniel D. Von Hoff.
Mitsuo Shimada, MD, Ph.D., FACS
Tokushima, Japan
Editorial Board
Mitsuo SHIMADA, MD, PhD., Professor and Chairman of Department of Surgery, Tokushima University.
Dr. Shimada is a prominent HBP surgeon who made numerous contribution to clinical and research advances in this area.
He is a member of the Executive Committee of the IASGO.
Curriculum Vitae
Mohamed Abdel Wahab, MD
Mansoura, Egypt
Editorial Board
Professor of Surgery and Gastroenterology, Gastroenterology Center, University of Mansoura, Egypt
Dr. Abdel Wahab is a prominent Egyptian HBP surgeon who made numerous contribution to clinical and research advances in this area. He is a member of the Executive Committee of the IASGO.
Curriculum Vitae
Philippe Bachellier, MD, Ph.D.
Strasbourg, France
Editorial Board
Professor of Surgery and Chairman HPB Surgery Department of HPB Surgery & Transplantation University Hospital of Hautepierre Strasbourg, France.
Rawisak Chanwat, MD, FRCST
Bangkok, Thailand
Editorial Board
Department of Surgery, National Cancer Institute of Thailand.
Dr. Chanwat, is the Chairman of Department of Surgery, National Cancer Institute. He is an expert in laparoscopic liver resection (LLR).
Razvan Iacob, MD, Ph.D.
Bucharest, Romania
Editorial Board
Lecturer at “Carol Davila” University and Medicine,senior physician in gastroenterology at Fundeni Clinical Institute, Bucharest, Romania
Curriculum Vitae
Renata Dobrila-Dintinjana, MD, Ph.D.
Rijeka, Croatia
Editorial Board
Prof. Renata Dobrila-Dintinjana is a physician, specialist in internal medicine, subspecialist in medical oncology, Professor at School of Medicine University Rijeka.
Prof. (Dr.) Renata Dobrila is presently working as Head of Department for Radiotherapy and Oncology, Clinical Hospital Centre Rijeka and Professor of Internal Medicine on School of Medicine, University of Rijeka, Croatia.
Curriculum Vitae
Rui Miguel Martins, MD, Ph.D.
Editorial Board
Department of General Surgery, Coimbra Hospital and University Center
Hospital Assistant of General Surgery, Portuguese Institute of Oncology of Coimbra Francisco Gentil
Curriculum Vitae
Ser Yee Lee, MBBS, MMED, MSC, FAMS, FRCS
Singapore, Singapore
Editorial Board
Dr. Lee Ser Yee specializes in Hepatopancreatobiliary surgery (HPB), Liver transplantation, Minimally-Invasive Surgery (MIS). He serves as the director of the Liver and MIS program at the Department of HPB and Transplant Surgery at Singapore General Hospital (SGH).
Curriculum Vitae
Shugo Mizuno, MD, Ph.D.
Mie, Japan
Editorial Board
Shugo MIZUNO was born in 1969. He got MD in 1995 (1989-1995), and PhD degree in 2001 from Mie University. Current his position is Professor and Chairman Hepatobiliary Pancreatic & Transplant Surgery, Mie University Graduate School of Medicine, and Director of Organ Transplantation Center at Mie University Hospital, Japan. His clinical specialty is liver transplantation and hepatobiliary and pancreas (HBP) surgery including oncology, extensive and minimal invasive surgery. For locally advanced pancreatic cancer, he undergo pancreatectomy after chemoradiotherapy. His research interest is focused on liver regeneration and ischemia reperfusion injury in the liver.
Si Young Song, MD, Ph.D.
Seoul, Korea
Editorial Board
Professor, Department of Internal Medicine, Division of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea http://medicine.yonsei.ac.kr
Dr. Si Young Song is the Honorary President of Korean Society of Gastrointestinal Cancer, and a member of the Executive Committee of the IASGO.
Curriculum Vitae
Sónia Vilaça, MD
Editorial Board
General Surgery Graduate Assistant, Hepatobiliopancreatic Division
General Surgery Service, Hospital de Braga, Portugal
Sorin Alexandrescu, MD, Ph.D.
Bucharest, Romania
Editorial Board
Dan Setlacec Centre of General Surgery and Liver Transplantation, Fundeni Clinical Institute, Bucharest, Romania
Curriculum Vitae
Speranţa Iacob, MD, Ph.D.
Bucharest, Romania
Editorial Board
Speranţa Iacob Lecturer at “Carol Davila” University and Medicine, senior physician in gastroenterology at Fundeni Clinical Institute, National Representative in the European Board for Transplant Medicine (since 2012).
Curriculum Vitae
Susumu Eguchi, MD, Ph.D., FACS, FEBS
Nagasaki, Japan
Editorial Board
Susumu Eguchi, M.D., FACS, FEBS, Professor and Chairman, Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Dr. Eguchi is a prominent HBP surgeon, specialized in Gastroenterological Surgery, Transplantation Surgery, Hepato-Biliary Pancreatic Surgery, Portal hypertension and Spleen Surgery. His research work focuses on liver transplantation, liver regeneration, hepatocyte-based therapy, and digestive system cancers.
Curriculum Vitae
Taizo Hibi, MD, Ph.D., FACS
Kumamoto, Japan
Editorial Board
Department of Transplantation and Pediatric Surgery, Kumamoto University Hospital, Kumamoto, Japan.
Dr. Hibi is Professor and Chairman, Department of Pediatric Surgery and Transplantation Kumamoto University Graduate School of Medical Sciences, and Director, Organ Transplant Center, Kumamoto University Hospital.
Tan-To Cheung, MD, MS, FRCSEd, FCSHK, FHKAM(Surgery)
Hong Kong
Editorial Board
Tan To Cheung, MBBS, MS, FRCS(Ed), FCSHK, FHKAM, is the Chief of the Division of Hepatobiliary and Pancreatic Surgery within the Department of Surgery, Queen Mary Hospital, the University of Hong Kong, and aCouncil member of the Hong Kong Society of Hepatobiliary and Pancreatic Surgery and Board of Director of Hong Kong Liver foundation. He is also Associate Professor of Surgery at the University of Hong Kong.
Curriculum Vitae
Tanios S. Bekaii-Saab, MD
Phoenix, Arizona
Editorial Board
Tanios S. Bekaii-Saab, M.D., conducts clinical and translational research focused on developing anti-cancer agents for patients with gastrointestinal cancers. Dr. Bekaii-Saab collaborates extensively with various scientists and industry partners to design and execute innovative clinical trials, including many first-in-human studies. He also leads the Mayo Clinic-supported cancer research consortium Academic and Community Cancer Research United (ACCRU) and is one of the leading clinician-scientists in the Alliance for Clinical Trials in Oncology, a National Cancer Institute (NCI)-supported cooperative research group.
Dr. Bekaii-Saab's research includes a large focus on the incorporation of agents that target the multiple facets of cancer, including genetic and epigenetic drivers, as well as the feeding microenvironment and the immune milieu. His work includes two recent discoveries as co-inventor of a molecule that targets cancer-related cachexia (AR-42) and an anti-PD-1 vaccine. His research has also led to the launch of a number of phase II and III clinical trials, including a recent trial with a cancer stem cell inhibitor (napabucasin) in pancreatic cancer, the development of an inhibitor of fibroblast growth factor receptor (FGFR) fusion genes in bile duct cancers, and a contribution to the pivotal study that led to the regulatory approval of nanoliposomal irinotecan for treating pancreatic cancer.
Thawatchai Akaraviputh, MD
Bangkok, Thailand
Editorial Board
Dr. Thawatchai Akaraviputh is a lecturer of the Department of Surgery, Faculty of Medicine Siriraj Hospital and an endo-laparoscopic surgeon.
Curriculum Vitae
Thomas B. Brunner, MD, Ph.D.
Magdeburg, Germany
Editorial Board
Thomas B. Brunner is the director of the Department for Radiation Therapy at the Otto-von-Guericke-University Magdeburg, Germany which is situated 150 km / 90 miles west of Berlin. He studied medicine in Erlangen until 1995 including an ERASMUS year at the Université de Haute Bretagne in Rennes, France. He then took up an activity in radiotherapy at the University of Erlangen. With a DFG grant, he completed a postdoctoral fellowship in the US from 2001 onwards at the Department of Radiation Oncology of the University of Pennsylvania, Philadelphia, where he studied molecular mechanisms of radiation sensitivity of pancreatic cancer. After returning to the University of Erlangen in 2004, he passed his board certification for radiotherapy and he earned his habilitation, a German PhD-like qualification, in 2005. From 2007 to 2012, he was Honorary Consultant at the Oxford Churchill Hospital and also led a research group at the University of Oxford at the Gray Institute for Radiation Oncology and Biology. His research focus there was the interaction of tumor cells with the tumor milieu. As Professor of Translational Clinical Oncology, he also led the Master's course in Radiation Biology. He then became vice chair at the Department of Radiation Therapy of the University Hospital Freiburg before moving to Magdeburg to lead the University Department of Radiation Oncology.
Curriculum Vitae
Toru Beppu, MD, Ph.D., FACS
Kumamoto, Japan
Editorial Board
Kumamoto University, Kumadai - Department of Gastroenterological Surgery (Med Grad) and Department of Multidisciplinary Treatment for Gastroenterological Cancer, Japan
Traian Dumitraşcu, MD, Ph.D.
Bucharest, Romania
Editorial Board
Traian Dumitraşcu is a senior surgeon and Chair of the Department of Surgical Oncology (ad interim, from July 2018) at Center of General Surgery and Liver Transplantation in Fundeni Clinical Institute, Bucharest, Romania.
Curriculum Vitae
Wenming Wu, MD, Ph.D.
Beijing, China
Editorial Board
Wenming Wu, MD is Professor of General Surgery Department, current Vice President of Peking Union Medical College Hospital(PUMCH), Beijing, China, also the current President of Tibet Autonomous Region People's Hospital.
Curriculum Vitae
Wojciech G. Polak, MD, Ph.D.
Rotterdam, The Netherlands
Editorial Board
Wojciech Polak MD, PhD graduated in medicine “cum laude” at the Medical University in Wroclaw (Poland) in 1992. Between 1992 and 1993 he finished his internship in Klinikum Innestadt in Munich (Germany). From 1994 until 2000 he was a resident in general surgery at the Department of Vascular, General and Transplantation Surgery at the University Hospital in Wroclaw, where he was appointed as a consultant surgeon after his training. In 1998 he defended his PhD thesis at the Medical University in Wroclaw. Between 2001 and 2003 he completed surgical fellowship in hepatobiliary surgery and liver transplantation at the Department of Surgery at the University Medical Center in Groningen, the Netherlands. After completion of his fellowship he returned to Poland to participate in kidney and liver transplant program at the Medical University in Wroclaw. In 2006 he worked as a consultant surgeon in hepatobiliary and transplant surgery at the Department of Surgery at the University Medical Center in Groningen. Since 2007 he is certified transplant surgeon at the European Board of Surgeons. In 2008 he defended his PhD thesis entitled “Technical aspects of liver transplantation” at the University of Groningen. The same year he was appointed as Associated Professor at the Medical University in Wroclaw. Since September 2009 Dr. Wojciech Polak works as a consultant transplant and hepatobiliary surgeon at the Department of Surgery at the Erasmus MC, University Medical Center Rotterdam, the Netherlands. In 2015 he was awarded with Honorary Diploma of European Board of Surgery (UEMS) in Hepatopancreatobiliary Surgery. Currently he is Surgical Director of Liver Transplant Program at Erasmus MC. His clinical and scientific area of expertise is liver transplantation and hepatobiliary surgery.
Curriculum Vitae